Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001493152-25-021552·Gilboa Udi
Schedule 13G ownership disclosure
NASUS PHARMA LTD
Ordinary Shares · CUSIP: M7071P109
Event date: 2025-09-30
- Filing-level shares
- 1,901,311.00
- Percent of class
- 21.1%
- Udi Gilboa
Shares: 1,901,311.00 · Class: 21.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-021552
- Form type
- SCHEDULE 13G
- Filer
- Gilboa Udi
- CIK
- CIK 1599094
- Filed
- Nov 10, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership